FIZTASOVIMAB
UNII TPH3PJ1D6U

Substance Identification & Data

This profile provides standardized clinical and technical data for Fiztasovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TPH3PJ1D6U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2467411-25-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TPH3PJ1D6U
CAS Registry Number
2467411-25-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FIZTASOVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188630
National Cancer Institute reference terminology for clinical and research data.
INN ID
12050
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fiztasovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FIZTASOVIMAB

Common Names & Synonyms

FIZTASOVIMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B) (HUMAN MONOCLONAL NPC-21 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NPC-21 .LAMBDA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus